Calpains Play a Role in Insulin Secretion and Action

Diabetes

Volumn 50, Issue 9, 2001, Pages 2013-2020

  Sreenan, Seamus K ^a,e   Zhou, Yun Ping ^a   Otani, Kenichi ^a,d   Hansen, Polly A ^b   Currie, Kevin P M ^a   Pan, Chien Yuan ^a   Lee, Jean Pyo ^a   Ostrega, Diane M ^a   Pugh, William ^a   Horikawa, Yukio ^a,f   Cox, Nancy J ^a   Hanis, Craig L ^c   Burant, Charles F ^b   Fox, Aaron P ^a   Bell, Graeme I ^a   Polonsky, Kenneth S ^d  

^a UNIVERSITY OF CHICAGO   (United States)

^b PFIZER INC   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d WASHINGTON UNIVERSITY   (United States)

^e Royal College of Surgeons in Ireland   (Ireland)

^f GUNMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALOXISTATIN; CALCIUM; CALPAIN; CYSTEINE PROTEINASE INHIBITOR; DEOXYGLUCOSE; DRUG DERIVATIVE; GLUCOSE; INSULIN; LEUCINE; N ACETYLLEUCYL LEUCYL METHIONINAL; N-ACETYLLEUCYL-LEUCYL-METHIONINAL; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; OLIGOPEPTIDE;

ADIPOCYTE; ANIMAL; ARTICLE; C57BL MOUSE; DRUG ANTAGONISM; DRUG EFFECT; ELECTRIC CONDUCTIVITY; IN VITRO STUDY; INTRACELLULAR MEMBRANE; METABOLISM; MOUSE; OSMOLARITY; PANCREAS ISLET; PHYSIOLOGY; SECRETION; SKELETAL MUSCLE; TIME;

ADIPOCYTES; ANIMALS; CALCIUM; CALPAIN; CYSTEINE PROTEINASE INHIBITORS; DEOXYGLUCOSE; ELECTRIC CONDUCTIVITY; GLUCOSE; INSULIN; INTRACELLULAR MEMBRANES; ISLETS OF LANGERHANS; LEUCINE; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; NADP; OLIGOPEPTIDES; OSMOLAR CONCENTRATION; TIME FACTORS;

EID: 0035458548     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.50.9.2013     Document Type: Article

References (22)

1. DeFronzo RA: Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Rev 5:177-269, 1997
2. Horikawa Y, Oda N, Cox NJ, Li X, Orho-Melander M, Hara M, Hinokio Y, Lindner TH, Mashima H, Schwarz PEH, del Bosque-Plata L, Horikawa Y, Oda Y, Yoshiuchi I, Colilla S, Polonsky KS, Wei S, Concannon P, Iwasaki N, Schulze J, Baier LJ, Bogardus C, Groop L, Boerwinkle E, Hanis CL, Bell GI: Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes. Nat Genet 26:163-75, 2000
3. Baier U, Permana P, Yang X, Pratley RE, Hanson RL, Shen G-Q, Mott D, Knowler WC, Cox NJ, Horikawa Y, Oda N, Bell GI, Bogardus C: A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. J Clin Invest 106:R69-R73, 2000
4. Carafoli E, Molinari M: Calpain: a protease in search of a function? Biochem Biophys Res Commun 247:193-203, 1998
5. Sorimachi H, Ishihura S, Suzuki K: Structure and physiological function of calpains. Biochem J 328:721-732, 1997
6. Pontoglio M, Sreenan S, Roe M, Pugh W, Ostrega D, Doyen A, Pick AJ, Baldwin A, Velho G, Froguel P, Levisetti M, Bonner-Weir S, Bell GI, Yaniv M, Polonsky KS: Defective insulin secretion in hepatocyte nuclear factor 1α deficient mice. J Clin Invest 101:2215-2222, 1998
7. Sreenan SK, Cockburn BN, Baldwin AC, Ostrega DM, Levisetti M, Grupe A, Bell GI, Stewart TA, Roe MW, Polonsky KS: Adaptation to hyperglycemia enhances insulin secretion in glucokinase-deficient mutant mice. Diabetes 47:1881-1888, 1998
8. Dukes ID, Sreenan S, Roe MW, Levisetti M, Zhou Y-P, Ostrega D, Bell GI, Pontoglio M, Yaniv M, Philipson L, Polonsky KS: Defective pancreatic β-cell glycolytic signaling in hepatocyte nuclear factor-1α-deficient mice. J Biol Chem 273:24457-24464, 1998
9. Rosser BG, Powers SP, Gores GJ: Calpain activity increases in hepatocytes following addition of ATP: demonstration by a novel fluorescent approach. J Biol Chem 268:23593-23600, 1993
10. Zhou Y-P, Priestman DA, Randle PJ, Grill VE: Fasting and decreased B cell sensitivity: important role for fatty acid-induced inhibition of PDH activity. Am J Physiol 270:E988-E994, 1996
11. Joshi C, Fernandez JM: Capacitance measurements: an analysis of the phase detector technique used to study exocytosis and endocytosis. Biophys J 53:885-892, 1988
12. Neher E, Marty A: Discrete changes of cell membrane capacitance observed under conditions of enhanced secretion in bovine adrenal chromaffin cells. Proc Natl Acad Sci U S A 79:6712-6716, 1982
13. 2+ channel trigger secretion with different efficacies in chromaffin cells. Nature 367:72-76, 1994
14. Burant CF, Lemmon SK, Treutelaar MK, Buse MG: Insulin resistance of denervated rat muscle: a model for impaired receptor-function coupling. Am J Physiol 247:E657-E666, 1984
15. Rodbell M: Metabolism of isolated fat cells. 1. Effects of hormones on glucose metabolism and lipolysis. J Biol Chem 239:375-380, 1964
16. Young DA, Uhl JJ, Cartee GD, Holloszy JO: Activation of glucose transport in muscle by prolonged exposure to insulin: effects of glucose and insulin concentrations. J Biol Chem 261:16049-16053, 1986
17. Gromada J, Holst JJ, Rorsman P: Cellular regulation of islet hormone secretion by the incretin hormone glucagon-like peptide 1. Pflügers Arch 435:583-594, 1998
18. Wollheim CB, Biden TJ: Second messenger function of inositol 1,4,5-triphosphate. J Biol Chem 261:8314-8319, 1986
19. Hill PA, Buttle DJ, Jones SJ, Boyde A, Murata M, Reynolds JJ, Meikle MC: Inhibition of bone resorption by selective inactivators of cysteine proteinases. J Cell Biochem 56:118-130, 1994
20. Shulman GI: Cellular mechanisms of insulin resistance. J Clin Invest 106:171-176, 2000
21. Lee AD, Hansen PA, Holloszy JO: Wortmannin inhibits insulin-stimulated but not contraction-stimulated glucose transport activity in skeletal muscle. FEBS Lett 361:51-54, 1995
22. Yeh JI, Gulve EA, Rameh L, Birnbaum MJ: The effects of wortmannin on rat skeletal muscle: dissociation of signaling pathways for insulin- and contraction-activated hexose transport. J Biol Chem 270:2107-2111, 1995